Have a feature idea you'd love to see implemented?
Let us know!
FBLG FibroBiologics Inc
Price (delayed)
$2.41
Market cap
$83.53M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.6
Enterprise value
$77.26M
We are a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple
Highlights
The company's debt fell by 20% YoY and by 15% QoQ
The net income has dropped by 114% year-on-year but it has grown by 9% since the previous quarter
FBLG's quick ratio has surged by 98% since the previous quarter but it has dropped by 86% year-on-year
The equity has shrunk by 74% YoY
Key stats
What are the main financial stats of FBLG
Market
Valuations
Earnings
Shares outstanding
34.66M
Market cap
$83.53M
Enterprise value
$77.26M
Price to earnings (P/E)
N/A
Price to book (P/B)
30.96
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$17.76M
EBITDA
-$17.21M
Free cash flow
-$10.52M
Per share
Balance sheet
Liquidity
EPS
-$0.6
Free cash flow per share
-$0.31
Book value per share
$0.08
Revenue per share
$0
TBVPS
$0.31
Total assets
$10.47M
Total liabilities
$7.73M
Debt
$1.56M
Equity
$2.74M
Working capital
$1.52M
Debt to equity
0.57
Current ratio
1.23
Quick ratio
1.17
Net debt/EBITDA
0.36
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-166.9%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
-468.5%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
FBLG stock price
How has the FibroBiologics stock price performed over time
Intraday
7.59%
1 week
-14.23%
1 month
-21.11%
1 year
N/A
YTD
N/A
QTD
-22.01%
Financial performance
How have FibroBiologics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$12.51M
Net income
-$17.78M
Gross margin
N/A
Net margin
N/A
The net income has dropped by 114% year-on-year but it has grown by 9% since the previous quarter
FibroBiologics's operating income has shrunk by 62% YoY and by 12% QoQ
Growth
What is FibroBiologics's growth rate over time
Valuation
What is FibroBiologics stock price valuation
P/E
N/A
P/B
30.96
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
FibroBiologics's EPS has shrunk by 54% YoY but it has increased by 10% QoQ
The equity has shrunk by 74% YoY
Efficiency
How efficient is FibroBiologics business performance
The ROA has shrunk by 104% YoY but it rose by 2.6% QoQ
Dividends
What is FBLG's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for FBLG.
Financial health
How did FibroBiologics financials performed over time
The total assets is 35% greater than the total liabilities
FibroBiologics's total liabilities has surged by 180% YoY but it has decreased by 32% QoQ
FBLG's quick ratio has surged by 98% since the previous quarter but it has dropped by 86% year-on-year
The company's debt is 43% lower than its equity
The debt to equity has soared by 174% since the previous quarter
The equity has shrunk by 74% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.